Page last updated: 2024-11-03

ono 1078 and Leukomalacia, Periventricular

ono 1078 has been researched along with Leukomalacia, Periventricular in 1 studies

pranlukast: SRS-A antagonist; leukotriene D4 receptor antagonist

Leukomalacia, Periventricular: Degeneration of white matter adjacent to the CEREBRAL VENTRICLES following cerebral hypoxia or BRAIN ISCHEMIA in neonates. The condition primarily affects white matter in the perfusion zone between superficial and deep branches of the MIDDLE CEREBRAL ARTERY. Clinical manifestations include VISION DISORDERS; CEREBRAL PALSY; PARAPLEGIA; SEIZURES; and cognitive disorders. (From Adams et al., Principles of Neurology, 6th ed, p1021; Joynt, Clinical Neurology, 1997, Ch4, pp30-1)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Ye, XY1
Wang, DY1
Xu, Y1
Wang, J1

Other Studies

1 other study available for ono 1078 and Leukomalacia, Periventricular

ArticleYear
[Effect of pranlukast on neonatal rats with periventricular leukomalacia].
    Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics, 2020, Volume: 22, Issue:6

    Topics: Animals; Animals, Newborn; Chromones; Leukomalacia, Periventricular; Rats; Receptors, G-Protein-Coup

2020